These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 17123911

  • 1. Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws.
    Biasotto M, Chiandussi S, Dore F, Rinaldi A, Rizzardi C, Cavalli F, Di Lenarda R.
    Acta Odontol Scand; 2006 Nov; 64(6):348-54. PubMed ID: 17123911
    [Abstract] [Full Text] [Related]

  • 2. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT, Chiang WF, Chuang CY, Chang SW.
    J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
    [Abstract] [Full Text] [Related]

  • 3. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.
    Magopoulos C, Karakinaris G, Telioudis Z, Vahtsevanos K, Dimitrakopoulos I, Antoniadis K, Delaroudis S.
    Am J Otolaryngol; 2007 May; 28(3):158-63. PubMed ID: 17499130
    [Abstract] [Full Text] [Related]

  • 4. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
    Hay KD, Bishop PA.
    N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review.
    Leite AF, Figueiredo PT, Melo NS, Acevedo AC, Cavalcanti MG, Paula LM, Paula AP, Guerra EN.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):14-21. PubMed ID: 16831667
    [Abstract] [Full Text] [Related]

  • 9. Bisphosphonate-associated osteonecrosis. A clinician's reference to patient management.
    Grewal VS, Fayans EP.
    N Y State Dent J; 2008 Jan; 74(1):38-44. PubMed ID: 18402375
    [Abstract] [Full Text] [Related]

  • 10. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS, Fayans EP.
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [Abstract] [Full Text] [Related]

  • 11. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I, Magopoulos C, Karakasis D.
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
    [Abstract] [Full Text] [Related]

  • 12. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE, Blake FA.
    Anticancer Res; 2007 Jul; 27(4A):1841-5. PubMed ID: 17649782
    [Abstract] [Full Text] [Related]

  • 13. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment.
    Ficarra G, Beninati F, Rubino I, Vannucchi A, Longo G, Tonelli P, Pini Prato G.
    J Clin Periodontol; 2005 Nov; 32(11):1123-8. PubMed ID: 16212571
    [Abstract] [Full Text] [Related]

  • 14. Management of osteonecrosis of the jaws in patients with history of bisphosphonates therapy.
    Antonini F, Pereira CC, Parente EV, Azambuja FG.
    J Craniofac Surg; 2010 Nov; 21(6):1962-6. PubMed ID: 21119470
    [Abstract] [Full Text] [Related]

  • 15. [Surgical treatment of maxillary osteonecrosis due to bisphosphonates using an Er:YAG (2940 nm) laser. Discussion of 17 clinical cases].
    Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M, Rocca EP, De Moor RJ, Nammour S.
    Rev Belge Med Dent (1984); 2009 Nov; 64(2):87-95. PubMed ID: 19681350
    [Abstract] [Full Text] [Related]

  • 16. Surgical management of bisphosphonate induced osteonecrosis of the jaws.
    Williamson RA.
    Int J Oral Maxillofac Surg; 2010 Mar; 39(3):251-5. PubMed ID: 20015614
    [Abstract] [Full Text] [Related]

  • 17. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
    Lobato JV, Rodrigues JM, Cavaleiro MV, Lobato JM, Xavier L, Santos JD, Maurício AC.
    Acta Med Port; 2007 Mar; 20(2):185-92. PubMed ID: 17868526
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
    Diego R, D'Orto O, Pagani D, Agazzi A, Marzano U, Derada Troletti G, Fontanella W, Pignataro L.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
    [Abstract] [Full Text] [Related]

  • 19. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
    Gallego L, Junquera L.
    Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371
    [Abstract] [Full Text] [Related]

  • 20. Nd:YAG laser biostimulation of bisphosphonate-associated necrosis of the jawbone with and without surgical treatment.
    Vescovi P, Merigo E, Meleti M, Fornaini C, Nammour S, Manfredi M.
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):628-32. PubMed ID: 17524535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.